A detailed history of Principal Financial Group Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 86,437 shares of CRMD stock, worth $980,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,437
Holding current value
$980,195
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$10.07 - $14.83 $870,420 - $1.28 Million
86,437 New
86,437 $1.03 Million
Q2 2024

Jul 29, 2024

BUY
$4.08 - $6.39 $41,734 - $65,363
10,229 New
10,229 $44,000
Q2 2020

Aug 05, 2020

SELL
$3.08 - $6.56 $60,749 - $129,389
-19,724 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$2.35 - $7.08 $157 - $474
67 Added 0.34%
19,724 $71,000
Q4 2019

Feb 05, 2020

SELL
$4.96 - $7.75 $34,412 - $53,769
-6,938 Reduced 26.09%
19,657 $143,000
Q3 2019

Nov 13, 2019

BUY
$6.38 - $9.69 $1,199 - $1,821
188 Added 0.71%
26,595 $170,000
Q2 2019

Aug 12, 2019

BUY
$5.93 - $10.57 $156,593 - $279,121
26,407 New
26,407 $237,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $467M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.